|
JP7600208B2
(ja)
*
|
2019-07-29 |
2024-12-16 |
ジョージア テック リサーチ コーポレイション |
拘束された脂質を含むナノ材料およびその使用
|
|
US12521451B2
(en)
|
2019-11-08 |
2026-01-13 |
Regeneron Pharmaceuticals, Inc. |
CRISPR and AAV strategies for x-linked juvenile retinoschisis therapy
|
|
CN115175894B
(zh)
*
|
2020-01-09 |
2024-09-06 |
盖德治疗有限责任公司 |
纳米材料
|
|
KR20230017783A
(ko)
|
2020-04-28 |
2023-02-06 |
인텔리아 테라퓨틱스, 인크. |
시험관내 세포 전달 방법
|
|
AU2021275223A1
(en)
|
2020-05-20 |
2023-02-02 |
Flagship Pioneering Innovations Vi, Llc. |
Coronavirus antigen compositions and their uses
|
|
IL298363A
(en)
|
2020-05-20 |
2023-01-01 |
Flagship Pioneering Innovations Vi Llc |
Immunogenic compositions and uses thereof
|
|
EP4158032A2
(en)
|
2020-05-29 |
2023-04-05 |
Flagship Pioneering Innovations VI, LLC |
Trem compositions and methods relating thereto
|
|
US20230203510A1
(en)
|
2020-05-29 |
2023-06-29 |
Flagship Pioneering Innovations Vi, Llc |
Trem compositions and methods relating thereto
|
|
EP4182296A1
(en)
*
|
2020-07-17 |
2023-05-24 |
Sanofi Pasteur |
Cleavable lipidic compounds, compositions containing thereof, and uses thereof
|
|
IL300947A
(en)
|
2020-09-03 |
2023-04-01 |
Flagship Pioneering Innovations Vi Llc |
Immunogenic compositions and uses thereof
|
|
WO2022060871A1
(en)
*
|
2020-09-15 |
2022-03-24 |
Verve Therapeutics, Inc. |
Lipid formulations for gene editing
|
|
MX2023004371A
(es)
|
2020-10-14 |
2023-07-26 |
George Mason Res Foundation Inc |
Lípidos ionizables, y métodos de fabricación y uso de los mismos.
|
|
EP4259792A1
(en)
|
2020-12-11 |
2023-10-18 |
Intellia Therapeutics, Inc. |
Polynucleotides, compositions, and methods for genome editing involving deamination
|
|
CN116887841A
(zh)
*
|
2020-12-21 |
2023-10-13 |
比姆医疗股份有限公司 |
包括酯连接缩醛的纳米材料
|
|
EP4262817A4
(en)
*
|
2020-12-21 |
2025-03-12 |
Beam Therapeutics Inc. |
NANOMATERIALS WITH ACETALS
|
|
JP2024508347A
(ja)
*
|
2020-12-21 |
2024-02-27 |
ビーム セラピューティクス インク. |
エステル結合アセタールを含むナノ材料
|
|
KR20230135585A
(ko)
|
2020-12-23 |
2023-09-25 |
플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 |
변형된 trem의 조성물 및 이의 용도
|
|
CN116761888A
(zh)
|
2021-01-20 |
2023-09-15 |
比姆医疗股份有限公司 |
纳米材料
|
|
EP4281080A4
(en)
*
|
2021-01-20 |
2025-09-24 |
Beam Therapeutics Inc |
NANOMATERIALS COMPRISING A BIODEGRADABLE ELEMENT
|
|
EP4313109A1
(en)
|
2021-03-31 |
2024-02-07 |
Flagship Pioneering Innovations V, Inc. |
Thanotransmission polypeptides and their use in treating cancer
|
|
CA3216873A1
(en)
*
|
2021-04-17 |
2022-10-22 |
Intellia Therapeutics, Inc. |
Lipid nanoparticle compositions
|
|
EP4322920A1
(en)
|
2021-04-17 |
2024-02-21 |
Intellia Therapeutics, Inc. |
Lipid nanoparticle compositions
|
|
US20240300977A1
(en)
|
2021-04-17 |
2024-09-12 |
Intellia Therapeutics, Inc. |
Inhibitors of dna-dependent protein kinase and compositions and uses thereof
|
|
PL4332086T3
(pl)
*
|
2021-04-28 |
2026-06-15 |
Fujifilm Corporation |
Związek lub jego sól, cząstki lipidowe, i kompozycja farmaceutyczna
|
|
TW202317764A
(zh)
|
2021-06-10 |
2023-05-01 |
美商英特利亞醫療公司 |
用於基因編輯之包含內部連接子之經修飾引導rna
|
|
CA3226487A1
(en)
*
|
2021-07-12 |
2023-02-23 |
University Of Cincinnati |
Ionizable lipids, lipid nanoparticles for mrna delivery and methods of making the same
|
|
WO2023023410A2
(en)
*
|
2021-07-12 |
2023-02-23 |
University Of Cincinnati |
Ionizable lipids, lipid nanoparticles for mrna delivery and methods of making the same
|
|
WO2023009547A1
(en)
|
2021-07-26 |
2023-02-02 |
Flagship Pioneering Innovations Vi, Llc |
Trem compositions and uses thereof
|
|
EP4380576A4
(en)
*
|
2021-08-03 |
2026-04-29 |
Verve Therapeutics Inc |
RNA TARGETED COMPOSITIONS AND ADMINISTRATION METHODS
|
|
WO2023044343A1
(en)
|
2021-09-14 |
2023-03-23 |
Renagade Therapeutics Management Inc. |
Acyclic lipids and methods of use thereof
|
|
AR127073A1
(es)
|
2021-09-17 |
2023-12-13 |
Flagship Pioneering Innovations Vi Llc |
Composiciones y métodos para producir polirribonucleótidos circulares
|
|
CN113773216B
(zh)
*
|
2021-09-30 |
2022-12-27 |
贵州大学 |
一种长链脂肪酸甘油醇类化合物Rubracin A、制备方法及其应用
|
|
JP7883580B2
(ja)
*
|
2021-10-08 |
2026-07-01 |
スージョウ・アボジェン・バイオサイエンシズ・カンパニー・リミテッド |
脂質化合物及び脂質ナノ粒子組成物
|
|
EP4419706A1
(en)
|
2021-10-18 |
2024-08-28 |
Flagship Pioneering Innovations VI, LLC |
Compositions and methods for purifying polyribonucleotides
|
|
KR20240090727A
(ko)
|
2021-10-22 |
2024-06-21 |
세일 바이오메디슨스, 인크. |
Mrna 백신 조성물
|
|
EP4426822A2
(en)
|
2021-11-03 |
2024-09-11 |
Intellia Therapeutics, Inc. |
Polynucleotides, compositions, and methods for genome editing
|
|
US20250002941A1
(en)
|
2021-11-23 |
2025-01-02 |
Sail Biomedicines, Inc. |
A bacteria-derived lipid composition and use thereof
|
|
IL312965A
(en)
|
2021-11-24 |
2024-07-01 |
Flagship Pioneering Innovations Vi Llc |
Immunogenic compositions and their uses
|
|
WO2023096990A1
(en)
|
2021-11-24 |
2023-06-01 |
Flagship Pioneering Innovation Vi, Llc |
Coronavirus immunogen compositions and their uses
|
|
MX2024006407A
(es)
|
2021-11-24 |
2024-08-19 |
Flagship Pioneering Innovations Vi Llc |
Composiciones de inmunogenos del virus varicela-zoster y sus usos.
|
|
CN118510896A
(zh)
|
2021-12-17 |
2024-08-16 |
旗舰创业创新六公司 |
用于在变性条件下富集环状rna的方法
|
|
WO2023121965A1
(en)
*
|
2021-12-20 |
2023-06-29 |
Beam Therapeutics Inc. |
Nanomaterial comprising diamines
|
|
CA3241488A1
(en)
*
|
2021-12-20 |
2023-06-29 |
Beam Therapeutics Inc. |
Ionizable amine lipids and lipid nanoparticles
|
|
EP4452239A1
(en)
|
2021-12-20 |
2024-10-30 |
Sail Biomedicines, Inc. |
Compositions comprising mrna and lipid reconstructed plant messenger packs
|
|
WO2023121964A1
(en)
*
|
2021-12-20 |
2023-06-29 |
Beam Therapeutics Inc. |
Nanomaterials comprising disulfides
|
|
EP4453201A1
(en)
|
2021-12-22 |
2024-10-30 |
Flagship Pioneering Innovations VI, LLC |
Compositions and methods for purifying polyribonucleotides
|
|
AU2022420620A1
(en)
|
2021-12-23 |
2024-07-04 |
Flagship Pioneering Innovations Vi, Llc |
Circular polyribonucleotides encoding antifusogenic polypeptides
|
|
JP2025502599A
(ja)
*
|
2021-12-23 |
2025-01-28 |
スージョウ・アボジェン・バイオサイエンシズ・カンパニー・リミテッド |
脂質化合物及び脂質ナノ粒子組成物
|
|
CA3242974A1
(en)
|
2021-12-29 |
2023-07-06 |
Shanghai Senhui Medicine Co., Ltd. |
LIPID AND COMPOSITION USED FOR ADMINISTRATION
|
|
JP2025504430A
(ja)
*
|
2022-01-17 |
2025-02-12 |
サノフイ |
脂質化合物及びその使用
|
|
CN114213347B
(zh)
*
|
2022-02-22 |
2022-05-20 |
中国科学院基础医学与肿瘤研究所(筹) |
一种双价可电离脂质化合物、组合物及其应用
|
|
CN114213346B
(zh)
*
|
2022-02-22 |
2022-05-20 |
中国科学院基础医学与肿瘤研究所(筹) |
一种双价可电离脂质化合物、组合物及其应用
|
|
US20250250227A1
(en)
*
|
2022-02-28 |
2025-08-07 |
Shenzhen Shenxin Biotechnology Co., Ltd. |
Amino lipid compound, preparation method therefor, composition thereof and use thereof
|
|
CN116354836A
(zh)
*
|
2022-03-25 |
2023-06-30 |
深圳市新合生物医疗科技有限公司 |
阳离子脂质化合物及其制备方法和应用、以及mRNA递送系统
|
|
CA3245624A1
(en)
|
2022-03-25 |
2023-09-28 |
Sail Biomedicines, Inc. |
NEW IONIZABLE LIPIDS AND LIPID NANOPARTICLES AND THEIR METHODS OF USE
|
|
CN116924923A
(zh)
*
|
2022-04-02 |
2023-10-24 |
科镁信(上海)生物医药科技有限公司 |
阳离子脂质、脂质体及用途
|
|
EP4504694A4
(en)
*
|
2022-04-05 |
2026-07-15 |
Capstan Therapeutics Inc |
IONIZABLE CATIONIC LIPIDS AND LIPID NANOPARTICLES
|
|
JP2025511756A
(ja)
|
2022-04-08 |
2025-04-16 |
フラッグシップ パイオニアリング イノベーションズ セブン,エルエルシー |
ワクチン及び関連する方法
|
|
EP4519243A4
(en)
*
|
2022-05-04 |
2026-04-22 |
Univ Pennsylvania |
Siloxane-based lipids, lipid nanoparticle compositions comprising them, and their methods of use for targeted administration
|
|
WO2023220083A1
(en)
|
2022-05-09 |
2023-11-16 |
Flagship Pioneering Innovations Vi, Llc |
Trem compositions and methods of use for treating proliferative disorders
|
|
JP2025516638A
(ja)
|
2022-05-13 |
2025-05-30 |
フラッグシップ パイオニアリング イノベーションズ セブン,エルエルシー |
二本鎖dna組成物及び関連する方法
|
|
WO2023230601A1
(en)
|
2022-05-27 |
2023-11-30 |
Beam Therapeutics Inc. |
Identification of nanoparticles for preferential tissue or cell targeting
|
|
US20250325492A1
(en)
*
|
2022-06-03 |
2025-10-23 |
University Of Cincinnati |
Ionizable lipids, lipid nanoparticles for mrna delivery and methods of making the same
|
|
CN119384498A
(zh)
|
2022-06-16 |
2025-01-28 |
因特利亚治疗公司 |
用于对细胞进行遗传修饰的方法和组合物
|
|
EP4544043A1
(en)
|
2022-06-22 |
2025-04-30 |
Flagship Pioneering Innovations VI, LLC |
Compositions of modified trems and uses thereof
|
|
KR20250042143A
(ko)
*
|
2022-06-23 |
2025-03-26 |
턴 바이오테크놀로지스 인코포레이티드 |
지질 구조 및 이를 포함하는 조성물
|
|
WO2024012270A1
(zh)
*
|
2022-07-11 |
2024-01-18 |
传信生物医药(苏州)有限公司 |
用于核酸的器官特异性递送组合物
|
|
CA3262260A1
(en)
|
2022-07-15 |
2025-06-12 |
Shenzhen Shenxin Biotechnology Co., Ltd. |
AMINO-LIPID COMPOUND, ITS PREPARATION PROCESS, ASSOCIATED COMPOSITION AND ASSOCIATED APPLICATION
|
|
CN115043790B
(zh)
*
|
2022-07-18 |
2023-09-26 |
贵州大学 |
一种对称杂环化合物、制备方法及其应用
|
|
EP4540222A1
(en)
|
2022-07-20 |
2025-04-23 |
Beam Therapeutics Inc. |
Nanomaterials comprising triols
|
|
CN119677852A
(zh)
|
2022-07-29 |
2025-03-21 |
麻省理工学院 |
抑制信号调节蛋白α(SIRPα)基因表达的组合物和方法
|
|
US20240042021A1
(en)
|
2022-08-01 |
2024-02-08 |
Flagship Pioneering Innovations Vii, Llc |
Immunomodulatory proteins and related methods
|
|
EP4569112A1
(en)
|
2022-08-12 |
2025-06-18 |
Remix Therapeutics Inc. |
Methods and compositions for modulating splicing at alternative splice sites
|
|
EP4581012A2
(en)
|
2022-08-31 |
2025-07-09 |
Sail Biomedicines, Inc. |
Novel ionizable lipids and lipid nanoparticles and methods of using the same
|
|
KR20250110209A
(ko)
|
2022-09-23 |
2025-07-18 |
엔크로마 바이오, 인크. |
Hbv 유전자 발현의 에피제네틱 조절을 위한 조성물 및 방법
|
|
WO2024077191A1
(en)
|
2022-10-05 |
2024-04-11 |
Flagship Pioneering Innovations V, Inc. |
Nucleic acid molecules encoding trif and additionalpolypeptides and their use in treating cancer
|
|
WO2024078614A1
(zh)
*
|
2022-10-13 |
2024-04-18 |
深圳深信生物科技有限公司 |
用于递送生物活性成分的氨基脂质化合物和脂质纳米颗粒
|
|
EP4612296A1
(en)
|
2022-10-31 |
2025-09-10 |
Flagship Pioneering Innovations VI, LLC |
Compositions and methods for purifying polyribonucleotides
|
|
WO2024102799A1
(en)
|
2022-11-08 |
2024-05-16 |
Flagship Pioneering Innovations Vi, Llc |
Compositions and methods for producing circular polyribonucleotides
|
|
EP4615424A1
(en)
|
2022-11-10 |
2025-09-17 |
Sail Biomedicines, Inc. |
Rna compositions comprising lipid nanoparticles or lipid reconstructed natural messenger packs
|
|
AU2023379598A1
(en)
*
|
2022-11-16 |
2025-05-08 |
Seawolf Therapeutics, Inc. |
Ionizable lipids and lipid nanoparticle compositions for the delivery of nucleic acids
|
|
WO2024128525A1
(ko)
*
|
2022-12-12 |
2024-06-20 |
한국과학기술연구원 |
신규한 지질 화합물 및 이를 포함하는 지질 나노입자 조성물
|
|
TW202430215A
(zh)
|
2022-12-14 |
2024-08-01 |
美商旗艦先鋒創新有限責任(Vii)公司 |
用於將治療劑遞送至骨之組成物和方法
|
|
EP4638783A2
(en)
|
2022-12-22 |
2025-10-29 |
Intellia Therapeutics, Inc. |
Methods for analyzing nucleic acid cargos of lipid nucleic acid assemblies
|
|
CN120418427A
(zh)
|
2022-12-23 |
2025-08-01 |
因特利亚治疗公司 |
用于基因组编辑的系统和方法
|
|
JP2025534494A
(ja)
*
|
2022-12-23 |
2025-10-15 |
グリーン・クロス・コーポレイション |
イオン化可能な脂質及びその使用
|
|
EP4648794A2
(en)
|
2023-01-09 |
2025-11-19 |
Flagship Pioneering Innovations VII, LLC |
Vaccines and related methods
|
|
WO2024151687A1
(en)
|
2023-01-09 |
2024-07-18 |
Flagship Pioneering Innovations V, Inc. |
Genetic switches and their use in treating cancer
|
|
US20240252520A1
(en)
|
2023-01-09 |
2024-08-01 |
Beth Israel Deaconess Medical Center, Inc. |
Therapeutic agents and their use for treating chronic wounds
|
|
US20240238473A1
(en)
|
2023-01-09 |
2024-07-18 |
Beth Israel Deaconess Medical Center, Inc. |
Recombinant nucleic acid molecules and their use in wound healing
|
|
JP2026503676A
(ja)
|
2023-01-27 |
2026-01-29 |
セイル バイオメディシンズ インコーポレイテッド |
修飾脂質組成物およびその使用
|
|
TW202438515A
(zh)
|
2023-02-06 |
2024-10-01 |
美商旗艦先鋒創新有限責任(Vii)公司 |
免疫調節組合物及相關方法
|
|
US20240293318A1
(en)
|
2023-02-13 |
2024-09-05 |
Flagship Pioneering Innovations Vii, Llc |
Cleavable linker-containing ionizable lipids and lipid carriers for therapeutic compositions
|
|
TW202446956A
(zh)
|
2023-02-17 |
2024-12-01 |
美商旗艦先鋒創新有限責任(Vii)公司 |
包含經修飾的胞嘧啶的dna組成物
|
|
KR20250151437A
(ko)
|
2023-02-17 |
2025-10-21 |
플래그쉽 파이어니어링 이노베이션스 Vii, 엘엘씨 |
변형된 우라실을 포함하는 dna 조성물
|
|
EP4680750A1
(en)
|
2023-03-15 |
2026-01-21 |
Flagship Pioneering Innovations VI, LLC |
Compositions comprising polyribonucleotides and uses thereof
|
|
EP4680276A1
(en)
|
2023-03-15 |
2026-01-21 |
Flagship Pioneering Innovations VI, LLC |
Immunogenic compositions and uses thereof
|
|
WO2024192528A1
(en)
*
|
2023-03-22 |
2024-09-26 |
Nanovation Therapeutics Inc. |
Ionizable anionic lipids
|
|
WO2024199282A1
(zh)
*
|
2023-03-28 |
2024-10-03 |
苏州艾博生物科技有限公司 |
脂质化合物和脂质纳米颗粒组合物
|
|
EP4692059A1
(en)
*
|
2023-03-29 |
2026-02-11 |
Tohoku University |
Cationic lipid having disulfide bond
|
|
WO2024216128A1
(en)
|
2023-04-12 |
2024-10-17 |
Flagship Pioneering Innovations Vi, Llc |
Trems for use in correction of missense mutations
|
|
AU2024255972A1
(en)
|
2023-04-12 |
2025-10-23 |
Flagship Pioneering Innovations Vi, Llc |
Modified trems, compositions, and related methods thereof
|
|
WO2024220752A2
(en)
|
2023-04-19 |
2024-10-24 |
Sail Biomedicines, Inc. |
Rna therapeutic compositions
|
|
WO2024220712A2
(en)
|
2023-04-19 |
2024-10-24 |
Sail Biomedicines, Inc. |
Vaccine compositions
|
|
EP4698150A1
(en)
|
2023-04-19 |
2026-02-25 |
Sail Biomedicines, Inc. |
Delivery of polynucleotides from lipid nanoparticles comprising rna and ionizable lipids
|
|
WO2024220746A2
(en)
|
2023-04-21 |
2024-10-24 |
Flagship Pioneering Innovations Vii, Llc |
Rnai agents targeting fatty acid synthase and related methods
|
|
WO2024229032A2
(en)
*
|
2023-05-01 |
2024-11-07 |
Factor Bioscience Inc. |
Multivalent ionizable lipid delivery systems
|
|
JP2026523341A
(ja)
|
2023-05-15 |
2026-07-14 |
エヌクロマ・バイオ,インコーポレーテッド |
Hbv遺伝子発現のエピジェネティック調節のための組成物および方法
|
|
EP4719352A1
(en)
|
2023-05-31 |
2026-04-08 |
Capstan Therapeutics, Inc. |
Lipid nanoparticle formulations and compositions
|
|
WO2024258829A1
(en)
|
2023-06-12 |
2024-12-19 |
Flagship Pioneering Innovations Vii, Llc |
Sars-cov-2 vaccine compositions and related methods
|
|
EP4736848A1
(en)
|
2023-06-28 |
2026-05-06 |
Shanghai Regenelead Therapies Co., Ltd. |
Pharmaceutical composition containing cationic lipid and use thereof
|
|
WO2025006684A1
(en)
|
2023-06-28 |
2025-01-02 |
Flagship Pioneering Innovations Vi, Llc |
Circular polyribonucleotides encoding antifusogenic polypeptides
|
|
CN117024323A
(zh)
*
|
2023-07-21 |
2023-11-10 |
中国科学院基础医学与肿瘤研究所(筹) |
一种可降解、可电离的阳离子脂材及其应用
|
|
KR20260044217A
(ko)
|
2023-07-25 |
2026-04-01 |
플래그쉽 파이어니어링 이노베이션스 Vii, 엘엘씨 |
Cas 엔도뉴클레아제 및 관련 방법
|
|
EP4762030A1
(en)
*
|
2023-08-16 |
2026-06-24 |
Beam Therapeutics Inc. |
Ionizable lipids with branched head groups
|
|
WO2025042786A1
(en)
|
2023-08-18 |
2025-02-27 |
Flagship Pioneering Innovations Vi, Llc |
Compositions comprising circular polyribonucleotides and uses thereof
|
|
WO2025049481A1
(en)
|
2023-08-28 |
2025-03-06 |
Intellia Therapeutics, Inc. |
Methods of editing an hla-a gene in vitro
|
|
WO2025045247A1
(en)
*
|
2023-08-31 |
2025-03-06 |
Geneditbio Limited |
Nucleic acids encoding crispr-associated proteins and uses thereof
|
|
WO2025054236A2
(en)
|
2023-09-06 |
2025-03-13 |
Flagship Pioneering Innovations Vii, Llc |
Sars-cov-2 vaccine compositions and related methods
|
|
KR20260094503A
(ko)
*
|
2023-09-13 |
2026-06-22 |
테세라 테라퓨틱스, 인크. |
치료용 페이로드를 세포에 전달하기 위한 지질 나노입자
|
|
IL327035A
(en)
|
2023-09-18 |
2026-05-01 |
Flagship Pioneering Innovations Vii Llc |
Ionizable lipidoid compositions and their medical uses
|
|
WO2025072331A1
(en)
|
2023-09-26 |
2025-04-03 |
Flagship Pioneering Innovations Vii, Llc |
Cas nucleases and related methods
|
|
US20250127728A1
(en)
*
|
2023-10-05 |
2025-04-24 |
Capstan Therapeutics, Inc. |
Constrained Ionizable Cationic Lipids and Lipid Nanoparticles
|
|
WO2025096807A2
(en)
|
2023-10-31 |
2025-05-08 |
Flagship Pioneering Innovations Vii, Llc |
Novel therapeutic dna forms
|
|
KR20260113064A
(ko)
|
2023-11-14 |
2026-07-21 |
플래그쉽 파이어니어링 이노베이션스 Vii, 엘엘씨 |
이온화 가능한 리피도이드 조성물 및 이의 치료적 용도
|
|
WO2025106915A1
(en)
|
2023-11-17 |
2025-05-22 |
Sail Biomedicines, Inc. |
Circular polyribonucleotides encoding glucagon-like peptide 1 (glp-1) and uses thereof
|
|
WO2025106930A1
(en)
|
2023-11-17 |
2025-05-22 |
Sail Biomedicines, Inc. |
Circular polyribonucleotides encoding glucagon-like peptide 2 (glp-2) and uses thereof
|
|
WO2025111454A1
(en)
*
|
2023-11-21 |
2025-05-30 |
University Of Cincinnati |
Ionizable lipids, lipid nanoparticles for mrna delivery and methods of making the same
|
|
US20250161347A1
(en)
|
2023-11-22 |
2025-05-22 |
Flagship Pioneering Innovations Vii, Llc |
Methods and compositions for treating non-alcoholic fatty liver disease
|
|
WO2025117877A2
(en)
|
2023-12-01 |
2025-06-05 |
Flagship Pioneering Innovations Vii, Llc |
Cas nucleases and related methods
|
|
WO2025128871A2
(en)
|
2023-12-13 |
2025-06-19 |
Renagade Therapeutics Management Inc. |
Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and therapeutic agents
|
|
WO2025137301A1
(en)
|
2023-12-20 |
2025-06-26 |
Intellia Therapeutics, Inc. |
Methods for rapid engineering of cells
|
|
US20250375499A1
(en)
|
2024-01-26 |
2025-12-11 |
Flagship Pioneering Innovations Vii, Llc |
Immunoreceptor inhibitory proteins and related methods
|
|
US20250381150A1
(en)
|
2024-03-08 |
2025-12-18 |
Genzyme Corporation |
Lipid nanoparticles
|
|
WO2025193861A2
(en)
*
|
2024-03-12 |
2025-09-18 |
Tessera Therapeutics, Inc. |
Lipid nanoparticles for delivery of therapeutic payloads to cells
|
|
WO2025194019A1
(en)
|
2024-03-14 |
2025-09-18 |
Flagship Pioneering Innovations Vii, Llc |
Methods for treating liver fibrosis and non-alcoholic fatty liver disease
|
|
WO2025212932A1
(en)
*
|
2024-04-03 |
2025-10-09 |
Intellia Therapeutics, Inc. |
Methods of synthesizing amine lipids
|
|
WO2025217129A1
(en)
*
|
2024-04-08 |
2025-10-16 |
Popvax Private Limited |
Novel lipids for delivery of nucleic acid therapeutics
|
|
WO2025217275A2
(en)
|
2024-04-10 |
2025-10-16 |
Flagship Pioneering Innovations Vii, Llc |
Immune cell targeted compositions and related methods
|
|
WO2025217452A1
(en)
*
|
2024-04-11 |
2025-10-16 |
Capstan Therapeutics, Inc. |
Constrained ionizable cationic lipids and lipid nanoparticles
|
|
TW202613158A
(zh)
|
2024-05-16 |
2026-04-01 |
美商旗艦先鋒創新有限責任(Vii)公司 |
免疫受體抑制蛋白及相關方法
|
|
WO2025240946A1
(en)
|
2024-05-17 |
2025-11-20 |
Intellia Therapeutics, Inc. |
Lipid nanoparticles and lipid nanoparticle compositions
|
|
WO2025245188A2
(en)
|
2024-05-21 |
2025-11-27 |
Flagship Pioneering Innovations Vii, Llc |
Methods of treating liver steatosis and non-alcoholic fatty liver disease
|
|
WO2025245111A1
(en)
|
2024-05-22 |
2025-11-27 |
Flagship Pioneering Innovations Vii, Llc |
Immunoreceptor targeting proteins and related methods
|
|
WO2025250729A1
(en)
*
|
2024-05-29 |
2025-12-04 |
Liberate Bio, Inc. |
Lipid compounds, compositions, and uses thereof
|
|
WO2025250730A1
(en)
*
|
2024-05-29 |
2025-12-04 |
Liberate Bio, Inc. |
Lipid compounds, compositions, and uses thereof
|
|
US20260000702A1
(en)
|
2024-06-26 |
2026-01-01 |
Flagship Pioneering Innovations Vii, Llc |
Therapeutic circular dna forms
|
|
WO2026003582A2
(en)
|
2024-06-27 |
2026-01-02 |
Axelyf ehf. |
Lipids and lipid nanoparticles
|
|
WO2026029040A1
(ja)
*
|
2024-07-29 |
2026-02-05 |
日油株式会社 |
アミノ脂質及び脂質ナノ粒子
|
|
WO2026030375A2
(en)
|
2024-07-30 |
2026-02-05 |
Genzyme Corporation |
Lipid nanoparticles and methods of manufacture and use thereof
|
|
WO2026035680A1
(en)
|
2024-08-06 |
2026-02-12 |
Kernal Biologics, Inc. |
Compositions and methods for delivery of agents
|
|
WO2026055543A1
(en)
|
2024-09-06 |
2026-03-12 |
Flagship Pioneering Innovations Vii, Llc |
Modified dna compositions and related methods
|
|
WO2026055547A1
(en)
|
2024-09-06 |
2026-03-12 |
Flagship Pioneering Innovations Vii, Llc |
Dna compositions and related methods
|
|
WO2026064313A1
(en)
|
2024-09-17 |
2026-03-26 |
Flagship Pioneering Innovations Vii, Llc |
Rna compositions and related methods
|
|
WO2026085300A1
(en)
|
2024-10-16 |
2026-04-23 |
Flagship Pioneering Innovations Vii, Llc |
Compositions and methods
|
|
WO2026097018A1
(en)
|
2024-11-04 |
2026-05-07 |
Intellia Therapeutics, Inc. |
Polypeptides, polynucleotides, compositions, and methods for genome editing involving chromatin remodelers
|
|
WO2026102108A1
(en)
|
2024-11-07 |
2026-05-15 |
Flagship Pioneering Innovations Vii, Llc |
Dna production methods
|
|
WO2026122747A2
(en)
|
2024-12-05 |
2026-06-11 |
Flagship Pioneering Innovations Vii, Llc |
Novel immunomodulatory proteins and related methods
|
|
WO2026122996A1
(en)
*
|
2024-12-06 |
2026-06-11 |
Tessera Therapeutics, Inc. |
Lipid nanoparticles for delivery of therapeutic payloads to cells
|
|
WO2026136246A1
(en)
*
|
2024-12-16 |
2026-06-25 |
Acuitas Therapeutics, Inc. |
Novel lipid compounds and methods of their use
|
|
WO2026142951A1
(en)
|
2024-12-23 |
2026-07-02 |
Genzyme Corporation |
Pharmaceutical system
|
|
WO2026151879A1
(en)
|
2025-01-10 |
2026-07-16 |
Flagship Pioneering Innovations Vii, Llc |
Vaccine compositions and methods
|
|
WO2026152023A1
(en)
|
2025-01-10 |
2026-07-16 |
Sail Biomedicines, Inc. |
Lipid compounds, lipid nanoparticle compositions and use thereof with polyribonucleotides
|
|
WO2026152164A1
(en)
|
2025-01-13 |
2026-07-16 |
Sail Biomedicines, Inc. |
Cd5-targeted lipid nanoparticles encapsulating polyribonucleotides encoding chimeric antigen receptors, and methods to generate car-expressing t cells in vivo
|
|
WO2026161677A1
(en)
|
2025-01-24 |
2026-07-30 |
Flagship Pioneering Innovations Vii, Llc |
Compositions and methods
|
|
WO2026163162A1
(en)
|
2025-01-31 |
2026-08-06 |
Intellia Therapeutics, Inc. |
Enhanced cas9 variants and uses thereof
|